Effect of Naloxegol on Gastric, Small Bowel, and Colonic Transit in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

May 10, 2017

Study Completion Date

May 10, 2017

Conditions
Constipation Drug Induced
Interventions
DRUG

Naloxegol

25mg daily

DRUG

Codeine

30mg 4 times daily

DRUG

codeine placebo

4 times daily (placebo will be made to match the codeine)

DRUG

naloxegol placebo

placebo will match naloxegol, given daily

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Michael Camilleri

OTHER